Friday, October 24, 2008
The results of this 36-month study are published in the New England Journal of Medicine (abstract available here)
Phase 3 trials are currently under way and still recruiting (see Genzyme and Clinical Trials here and here). If Phase 2 results are confirmed, researchers are excited that this could be a powerful drug when used early enough in the disease process.
For the experience of one trial participate, read David's Campath Story.
Lisa Emrich is author of the blog Brass and Ivory: Life with MS and RA and founder of the Carnival of MS Bloggers.
